Velpharm received a loan from the FRP in the amount of 172 million rubles
The dynamically developing group of companies "Bright Way" continues to implement significant projects in the Kurgan region.
The Velpharm pharmaceutical plant has launched a new project - the organization of the production of the pharmaceutical substance Bismuthate tripotassium dicitrate, which is on the list of strategically important drugs and the production increase of the antiulcer drug Vitridinol based on mentioned substance.
The production technology of the pharmaceutical substance Bismuthate tripotassium dicitrate, developed by the Institute of Solid State Chemistry and Mechanochemistry of the SB RAS, provides an increased safety profile and improved pharmacological properties, primarily due to a more pronounced bacteriostatic effect.
The implementation of this project will allow expanding the list of manufactured pharmaceutical substances based on bismuth compounds and considering the substances obtained in the future, as well as medicines based on them, as a highly liquid product that will be able to replace imported products on the Russian pharmaceutical market and have a high export potential.